EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Resistance-guided therapy and integration of novel therapeutics are key to facilitating antimicrobial stewardship for sexually transmitted infections

Lao-Tzu Allan-Blitz iD, Jeffrey D Klausner iD

Antimicrobial Stewardship & Healthcare Epidemiology · 2026 · 6 (1)

DOI: 10.1017/ash.2026.10940 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Antimicrobial Stewardship & Healthcare Epidemiology, online erschienen am 29.10.2026. Verfasst von Lao-Tzu Allan-Blitz und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of California Los Angeles, USA. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We read with great interest the article by Mayi et al. which discussed antimicrobial stewardship with respect to sexually transmitted infections (STIs). 1 We commend the authors for highlighting this important topic.Neisseria (N.) gonorrhoeae is one of the top five antimicrobial resistant threats to public health 2 -with continued reports documenting the emergence of ceftriaxone resistance (our last line empiric therapy).3,4 Similarly, Mycoplasma (M.) genitalium is one of three organisms on the U.S. Centers for Disease Control and Prevention Antimicrobial Resistance Watch List. 2 Thus, integrating antimicrobial stewardship into STI care and prevention is essential to mitigate the continued rise of drug resistance.However, two strategies central to facilitating antimicrobial stewardship within STIs have either been superficially mentioned or completely neglected: resistance-guided therapy and the incorporation of alternative empiric treatment options.Resistance-guided therapy is the use of rapid molecular assays for identifying genetic determinants of antimicrobial resistance.For both N. gonorrhoeae and M. genitalium, such assays are commercially available and STI treatment guidelines permit their use.In N. gonorrhoeae, resistance-guided therapy using ciprofloxacin among strains with a wildtype codon 91 in the gyrase A gene has been shown to be >97% clinically efficacious across three studies.[5][6][7] Real-world implementation of gyrase A genotyping led to a significant reduction in ceftriaxone use.Modeling demonstrated that rapid resistance testing can delay the emergence of ceftriaxone resistance.8 Across two clinical trials, more than 95% of M. genitalium infections were cured using macrolide-based resistance-guided therapy.9,10 That cure rate reflected a substantial improvement over the average 67% from other settings during the same time.11 Although no rapid molecular resistance test for either N. gonorrhoeae or M. genitalium are yet FDA-cleared, such tests have been CE marked in Europe and TGA approved in Australia.Further, a large clinical trial is underway evaluating the performance of three molecular resistance assays in N. gonorrhoeae, the results of which will support FDA 510(k) applications.

Autor:innen und Institutionen

  • University of California Los Angeles, USA.
  • Keck School of Medicine University of Southern California, USA.

ORCID-Profile: Lao-Tzu Allan-Blitz, Jeffrey D Klausner

Förderung

  • NIAID NIH HHS

Zitieren

APA

Allan-Blitz, L. T., & Klausner, J. D. (2026). Resistance-guided therapy and integration of novel therapeutics are key to facilitating antimicrobial stewardship for sexually transmitted infections. Antimicrobial Stewardship & Healthcare Epidemiology, 6(1). https://doi.org/10.1017/ash.2026.10940

Vancouver

Allan-Blitz LT, Klausner JD. Resistance-guided therapy and integration of novel therapeutics are key to facilitating antimicrobial stewardship for sexually transmitted infections. Antimicrobial Stewardship & Healthcare Epidemiology. 2026;6(1). doi:10.1017/ash.2026.10940

BibTeX
@article{AllanBlitz2026,
  author = {Allan-Blitz, Lao-Tzu and Klausner, Jeffrey D},
  title = {Resistance-guided therapy and integration of novel therapeutics are key to facilitating antimicrobial stewardship for sexually transmitted infections},
  journal = {Antimicrobial Stewardship & Healthcare Epidemiology},
  year = {2026},
  volume = {6},
  number = {1},
  doi = {10.1017/ash.2026.10940}
}
Kostenlos starten →